|Research and Development|
The Company's R&D strengths are in developing intellectual property in the area of non-infringing processes and resolving complex chemistry challenges. In the process, Aurobindo Pharma is developing new drug delivery systems, new dosage formulations, applying new technology for better processes.
The R&D Center, in Hyderabad covers over 13,000 sq.m, and provides a nurturing environment to a multi-disciplinary team of over 700 scientists striving for excellence.
The Centre meets cGLP requirements, and is focused on the areas of organic synthesis, analytical research, dosage form development, pharmacology, bio-equivalence studies and drug delivery systems.
The instrumentation and analytical knowledge base at the Centre facilitate,
This reflects the Company's commitment towards developing innovative technologies and creating a knowledge base in chemical synthesis, high quality generic formulations and development of drug delivery systems.
We aim to achieve the goals for wider access...ARVs / HIVs
Aurobindo has evolved into a knowledge driven...Strategic Alliance
Our Corporate Social Responsibility includes...Social Responsibility
Aurobindo Pharma has a team of more than...Global Family
Financial Results of Aurobindo Pharma...Investor Relations